Acute pancreatitis: the substantial human and financial costs.
about
The effect of activated protein C on experimental acute necrotizing pancreatitisRecent Advances in Managing Acute PancreatitisAssessment of PANC3 Score in Predicting Severity of Acute PancreatitisLeucocyte activation markers in clinical practice.Inhibitory effect of Patrinia scabiosaefolia on acute pancreatitis.Evolution of nutritional support in acute pancreatitis.The cost effectiveness of early management of acute appendicitis underlies the importance of curative surgical services to a primary healthcare programme.Pancreatic function, quality of life and costs at long-term follow-up after acute pancreatitisRole of endoscopic retrograde cholangiopancreatography in acute pancreatitis.Contemporary review of drug-induced pancreatitis: A different perspective.A comparison of the hospital costs of open vs. minimally invasive surgical management of necrotizing pancreatitis.New laboratory tests in acute pancreatitis.Pancreatic debridement in a district general hospital--viable or vulnerable?The role of Ca2+ influx in endocytic vacuole formation in pancreatic acinar cellsMarkers of inflammation in sepsis.Redox signaling in acute pancreatitis.Case mix, outcome, and activity for admissions to UK critical care units with severe acute pancreatitis: a secondary analysis of the ICNARC Case Mix Programme Database.Reduced lymphocyte count as an early marker for predicting infected pancreatic necrosis.Management of acute pancreatitis: from surgery to interventional intensive care.Surgery in the treatment of acute pancreatitis--open pancreatic necrosectomy.Drug-induced acute pancreatitisPotential mechanisms and significance of acute pancreatitis-associated liver injury.Interleukin-10 -1082A/G polymorphism is associated with the development of acute pancreatitis in a Chinese population.Clinical characteristics and management of patients with early acute severe pancreatitis: experience from a medical center in ChinaImproved outcome of severe acute pancreatitis in the intensive care unit.Ethanol toxicity in pancreatic acinar cells: mediation by nonoxidative fatty acid metabolitesSevere acute pancreatitis: pathogenetic aspects and prognostic factors.Galunisertib (LY2157299), a transforming growth factor-β receptor I kinase inhibitor, attenuates acute pancreatitis in rats.Angiotensin-converting enzyme gene DD genotype neither increases susceptibility to acute pancreatitis nor influences disease severity.Incidence of individual organ dysfunction in fatal acute pancreatitis: analysis of 1024 death records.Increased levels of 3-hydroxykynurenine parallel disease severity in human acute pancreatitis.Critical illness-related corticosteroid insufficiency in patients with severe acute biliary pancreatitis: a prospective cohort study.Acute pancreatitis: radiologic scores in predicting severity and outcome.Ocular actions of platelet-activating factor: clinical implications.The role of open necrosectomy in the current management of acute necrotizing pancreatitis: a review articleInfluence of interleukin gene polymorphisms on development of acute pancreatitis: a systematic review and meta-analysis.Prognostic markers in acute pancreatitis.Evidence for a role of mitogen-activated protein kinases in the treatment of experimental acute pancreatitis.Drug-induced acute pancreatitis: a review.Advances in Management of Acute Pancreatitis.
P2860
Q24811564-2E45A0F5-1CB4-4F46-B5A9-00857CC1B73EQ26766201-68A89486-672E-48C7-925D-B69F4A1A3E40Q33717984-9ABC5330-F43A-4749-BD76-EBBF453AD59EQ33727381-3B0D01A6-5F51-4531-8785-19F8F9759A77Q33868161-060B493E-5C58-4131-9A85-2511BDF95435Q33940274-DC900919-4EA5-4E75-B09B-A4A8F2C5A1BCQ34043627-B1CAE393-80AE-4CB7-ACD0-0C6731EECB0EQ34213749-ED9D8A2C-2FB9-4907-B0D3-DB4546E54571Q34382881-BF8D9327-766C-4814-8177-889F12406058Q34508837-8A1F2B26-1E7B-4704-98C6-D16A5182D177Q34625545-1A27B8A9-273E-47CF-BE4F-F6AFB4794A15Q34634636-3608A33E-F26D-4077-A587-9B71E9ADB74DQ34979514-F93CDD36-9379-4B3C-BD6D-52F9BF86E348Q35001139-6A677C74-F3A3-4FB5-A322-9381500D5AD2Q35055026-BCA95818-8437-4C46-A71D-304538640332Q35178638-510E4909-74DA-423C-AFAB-460E1F87056CQ35578923-7651AC1D-06BB-4062-BA61-39D1053C7426Q35820406-0B047EE2-A1E5-4EDD-8791-ECC93BBD1E60Q36041640-338202B7-A10D-4311-909F-333CCF32052DQ36235425-66181770-B4B6-4F7C-A9B4-08632A67EFADQ36360325-D8D9E991-6558-445B-9289-5226AD781A5EQ36459905-16CF95BD-D7EF-4BD4-BB6E-E7AC745AB452Q36464880-53C08A9A-92E4-4801-A707-148112B6196DQ36502614-C989EC9F-9706-4984-BEB1-E36F2249ECDEQ36676652-065A309B-0155-4FBF-9CE0-4E33D8C51458Q36986904-4B55708C-6C81-41CF-930F-6C750117AB6DQ37060412-D32942D2-F0A6-40B5-A036-59E7AC6AF435Q37183387-4018C6F3-4159-42B3-BDAD-F0DD21917C92Q37231069-B9491117-87D6-4FBF-9E7C-F03DD8752D5DQ37231138-3A211597-93E0-470A-899F-DDF0E4943ABEQ37285399-F7C78DA3-3944-4E01-922A-73A6255E6787Q37360332-DCC5D2A7-8DB8-44DD-BD5C-D8BE0B86F7D7Q37479277-3EEE2474-41FD-4466-9CC4-6887DBD64073Q38038206-A587ECEC-04FA-414B-B857-45B53942C396Q38083662-F2635B28-504E-4F84-9A9A-8782108C9DE0Q38145027-C8FA30F5-4C9F-40D4-A946-49DEAC87B7AFQ38197674-CBE60C1A-FD50-4872-A7D6-B5A942C19FF1Q38282070-6538D6A2-73BC-4275-A401-C3E6A8BB4BBAQ38398808-FD2C3D46-4E37-4A35-BABB-461ECEBAC1DBQ38576253-00E71E3A-9EDE-4E67-A90A-A20A443145A5
P2860
Acute pancreatitis: the substantial human and financial costs.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Acute pancreatitis: the substantial human and financial costs.
@en
Acute pancreatitis: the substantial human and financial costs.
@nl
type
label
Acute pancreatitis: the substantial human and financial costs.
@en
Acute pancreatitis: the substantial human and financial costs.
@nl
prefLabel
Acute pancreatitis: the substantial human and financial costs.
@en
Acute pancreatitis: the substantial human and financial costs.
@nl
P2093
P2860
P356
P1433
P1476
Acute pancreatitis: the substantial human and financial costs.
@en
P2093
P2860
P304
P356
10.1136/GUT.42.6.886
P407
P577
1998-06-01T00:00:00Z